Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Paul Hoyle"'
1
Abstract CT176: Effect of JAK/STAT or PI3Kδ plus PD-1 inhibition on the tumor microenvironment: Biomarker results from a phase Ib study in patients with advanced solid tumors
Autor: Niharika B. Mettu, Daniel Cho, John M. Kirkwood, Geoffrey T. Gibney, Nicholas Iannotti, Pamela N. Munster, Sherry Owens, Steven J. O'Day, F. Stephen Hodi, Michael Smith, Paul Hoyle
Publikováno v: Cancer Research. 78:CT176-CT176
Inhibitory pathway blockade has emerged as an important therapeutic modality in cancer. However, tumors escape immune surveillance by multiple mechanisms, which suggests a need to target combinations of distinct immunosuppressive pathways within the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f6319e2bffe2b9e41765535ee6fb18f
https://doi.org/10.1158/1538-7445.am2018-ct176
Zobrazit plný text záznamu
2
TGF-β1 and fibroblast growth factor-1 modify fibroblast growth factor-2 production in type II cells
Autor: Philip L. Sannes, Jody Khosla, Cheng-Ming Li, Paul Hoyle, Ines Pagan
Publikováno v: American Journal of Physiology-Lung Cellular and Molecular Physiology. 279:L1038-L1046
Fibroblast growth factor (FGF)-2, which stimulates DNA synthesis by type II cells in the lung, has been shown to be regulated by transforming growth factor (TGF)-β1, an important inflammatory cytokine, in vascular epithelium. The goal of this study
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d90747e2b6a5e6a60a16a7439c2baa
https://doi.org/10.1152/ajplung.2000.279.6.l1038
Zobrazit plný text záznamu
5
Transforming Growth Factor-β1 Modifies Fibroblast Growth Factor-2 Production in Type II Cells
Autor: Philip L. Sannes, Cheng-Ming Li, Paul Hoyle, Jody Khosla
Publikováno v: Chest. 120:S60-S61
Transforming growth factor (TGF)-beta(1) is an inflammatory cytokine that plays multiple roles in pulmonary fibrosis. In vascular epithelium, it has been shown to regulate production and activity of fibroblast growth factor (FGF)-2, a potent type II
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65ccee950f59f4ecef18ffd0ec5e3448
https://doi.org/10.1378/chest.120.1_suppl.s60
Zobrazit plný text záznamu
7
An evidence-based approach provides a quantitative assessment of the efficacy of esomeprazole for healing of erosive esophagitis based on disease severity
Autor: Barry Traxler, Douglas Levine, David A Johnson, Paul Hoyle
Publikováno v: The American Journal of Gastroenterology. 98:S16
An evidence-based approach provides a quantitative assessment of the efficacy of esomeprazole for healing of erosive esophagitis based on disease severity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::201d7d12e0ae6ec2319447933ff69ef1
https://doi.org/10.1016/s0002-9270(03)00815-3
Zobrazit plný text záznamu
8
Esomeprazole as maintenance therapy in erosive esophagitis: a quantitative assessment of efficacy using an evidence-based approach
Autor: Barry Traxler, Karsten Lauritsen, Douglas S. Levine, Paul Hoyle, David A. Johnson
Publikováno v: The American Journal of Gastroenterology. 98:S34
Esomeprazole as maintenance therapy in erosive esophagitis: a quantitative assessment of efficacy using an evidence-based approach
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f5d6f5fec3d4f52f63fab2d824d7b14
https://doi.org/10.1016/s0002-9270(03)00868-2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje